Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HEMOLAB

K-Number: K931992 · 1994-12-22

Decision Date1994-12-22
Product CodeGKP
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

HEMOLAB is the device name listed in this FDA 510(k) record. The listed applicant is Biomerieux Vitek, Inc.. It received FDA 510(k) clearance on 1994-12-22 under 510(k) number K931992. The device is classified under product code GKP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HEMOLAB?

HEMOLAB is a medical device that received FDA 510(k) clearance on 1994-12-22. The listed applicant is Biomerieux Vitek, Inc.. The 510(k) number is K931992.

When did HEMOLAB receive FDA 510(k) clearance?

HEMOLAB received FDA 510(k) clearance on 1994-12-22, under 510(k) number K931992.

Who is the listed applicant for HEMOLAB?

The FDA 510(k) record lists Biomerieux Vitek, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HEMOLAB?

The FDA product code for HEMOLAB is GKP.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Biomerieux Vitek, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 49 devices →

Related Devices (Code: GKP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑